Johnson & Johnson

Page 2 of 18

Johnson & Johnson exec Ashley McEvoy
Newsletters

A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?

By Emma Hinchliffe and Joey Abrams
December 7, 2023
J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand
Newsletters

J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand

By
December 7, 2023
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO
Newsletters

His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO

By
December 6, 2023
13 inflation-proof stocks to buy for 2024
Finance

13 inflation-proof stocks to buy for 2024

By Will Daniel and Scott DeCarlo
November 28, 2023
Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing 
Health

Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing 

By Jef Feeley and Bloomberg
October 26, 2023
Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato
Leadership

Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato

By
October 11, 2023
JNJ CEO Joaquin Duato appears at Fortune's CEO Initiative conference.
Finance

J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation

By
October 3, 2023
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
Health

Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case

By Jef Feeley and Bloomberg
September 28, 2023
McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
Health

McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers

By Joel Rosenblatt and Bloomberg
September 27, 2023
portrait of woman in suit jacket
Newsletters

This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business

By Emma Hinchliffe and Joey Abrams
September 15, 2023
Sudafed
Health

The top decongestant on the market doesn’t actually decongest, FDA says

By Matthew Perrone and The Associated Press
September 12, 2023
Tylenol poisoning suspect who tried to extort $1 million from Johnson & Johnson to ‘stop the killing’ dies at 76
Health

Tylenol poisoning suspect who tried to extort $1 million from Johnson & Johnson to ‘stop the killing’ dies at 76

By Mark Pratt and The Associated Press
July 11, 2023
From free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9 companies are competing on A.I. talent
Leadership

From free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9 companies are competing on A.I. talent

By
June 26, 2023
a person uses Johnson & Johnson baby powder.
Finance

Johnson & Johnson offers $8.9 billion settlement to roughly 60,000 people who claim its talc products gave them cancer

By Jef Feeley, Steven Church and Bloomberg
April 5, 2023
Impella patient
Health

Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood

By Madison Muller and Bloomberg
November 1, 2022

Most Popular